Genetics

Latest News

Are At-Home Genomic Tests Such as 23andMe Ethical?
Are At-Home Genomic Tests Such as 23andMe Ethical?

September 22nd 2023

Cheryl VerStrate, DNP, AGPCNP-BC, OCN, explains the pitfalls with at-home genomic tests and why nurses must be ready to talk to their patients about genetic counseling.

nurse with patient
Increase in Direct-to-Consumer Genomic Testing Yields New Ethical Considerations for Oncology Nurses

August 10th 2023

DNA
Oncology Nurses Play a Vital Role in Fostering Biomarker Testing Conversations With Patients

April 28th 2023

DNA Helix
CDCT1 Testing Study Highlights Pitfalls in Current NCCN Genetic Condition Screening Guidelines

April 18th 2023

precision medicine © Pavlo Syvak
Precision Medicine Advances Represent New Paradigm in Cancer Care

April 12th 2023

Latest CME Events & Activities

2022 BURST Year in Review™: Reflecting on Recent Evidence for Testing in Patients with GI Cancers

View More

2nd Annual International Congress on Pediatric Oncology

View More

2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

Register Now!

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

9th Annual School of Gastrointestinal Oncology® (SOGO®)

Register Now!

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Register Now!

New Targets, New Treatments, and New Combinations for the Management of Advanced Prostate Cancer

View More

BURST CME™: What Is the Real Risk in Lower-Risk MDS?

View More

BURST CME™: How Does Transfusion Burden Impact Real-World Outcomes in MDS?

View More

BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS

View More

How We Do It™: Integrating Gene Fusion Testing in Oncology Clinics for Patients with NSCLC

View More

Advances In™ KRAS Inhibition: Modern Considerations In Targeting KRAS-Mutated Lung, Colorectal, And Pancreatic Cancers

View More

The Latest on Acute Lymphocytic Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

A Focus on Acute Myeloid Leukemia

View More

Community Practice Connections™: The Newest Frontier in HR+ Breast Cancer—Targeting ESR1 Mutations with Next-Generation Endocrine Therapy

View More

Medical Crossfire®: Key Strategies to Prioritize Testing and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care

View More

Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Medical Crossfire™: How Do We Implement Personalized Treatment for Colorectal Cancer in the Community?

View More

Medical Crossfire®: Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Medical Crossfire®: Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

Live “Hot Seat”: Experts Face Your Hot-Button Questions on Maximizing PARP Inhibitors in Patients With CRPC

View More

Medical Crossfire®: Exploring Hot Topics in DLBCL: Sequencing CD19-Targeted Therapies, Strategies Post-CAR T Relapse, Novel Agents, and More!

View More

More News

© 2023 MJH Life Sciences

All rights reserved.